|
SETD6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.37130323657675E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.80076003792374E-12 |
| Normal-vs-Stage2 |
5.794900E-04 |
| Normal-vs-Stage3 |
1.50849999158709E-10 |
| Normal-vs-Stage4 |
1.20819999560595E-08 |
| Stage1-vs-Stage2 |
1.830020E-01 |
| Stage1-vs-Stage3 |
2.230200E-01 |
| Stage1-vs-Stage4 |
2.582400E-01 |
| Stage2-vs-Stage3 |
4.425800E-02 |
| Stage2-vs-Stage4 |
6.388300E-02 |
| Stage3-vs-Stage4 |
8.686000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.32419963883024E-10 |
| Normal-vs-AfricanAmerican |
4.24810000000386E-05 |
| Normal-vs-Asian |
1.56040003140845E-09 |
| Caucasian-vs-AfricanAmerican |
9.414400E-01 |
| Caucasian-vs-Asian |
3.779600E-01 |
| AfricanAmerican-vs-Asian |
6.488800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.17530000176558E-08 |
| Normal-vs-Female |
3.27793348020577E-12 |
| Male-vs-Female |
3.912800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.16504592032152E-12 |
| Normal-vs-Age(41-60Yrs) |
2.58590038271223E-10 |
| Normal-vs-Age(61-80Yrs) |
1.89490000002124E-06 |
| Normal-vs-Age(81-100Yrs) |
3.024600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.290800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.451200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.634800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.795000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.497400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.600200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.89010000000356E-05 |
| Classical-VS-Follicular |
1.835430E-01 |
| Classical-VS-Other |
2.594200E-01 |
| Classical-VS-Normal |
1.51110235435681E-11 |
| Tall-VS-Follicular |
1.86060999999293E-05 |
| Tall-VS-Other |
1.395730E-03 |
| Tall-VS-Normal |
2.87880830285303E-13 |
| Follicular-VS-Other |
6.237400E-01 |
| Follicular-VS-Normal |
5.59319999999808E-05 |
| Other-VS-Normal |
1.316440E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.04270000703622E-09 |
| Normal-vs-N1 |
3.96310000000399E-05 |
| N0-vs-N1 |
9.349000E-01 |
|
|
